“…This notion was further validated through mutational analyses. Deletion of I-exon promoters or regulatory regions (3′-RR) at the 3′-end of Igh abolished or severely reduced CSR, while replacing the inducible I-exon promoters with heterologous constitutive promoters drove CSR in a cytokine-independent fashion (Bottaro et al, 1994; Cogne et al, 1994; Jung et al, 1993; Kuzin et al, 2000; Lorenz, Jung, & Radbruch, et al, 1995; Manis, van der Stoep, et al, 1998; Michaelson, Giannini, & Birshtein, et al, 1995; Pinaud et al, 2001; Qiu, Harriman, & Stavnezer, et al, 1999; Seidl et al, 1998; Vincent-Fabert et al, 2010; Zhang et al, 1993). These studies thus provided experimental evidence for the notion that germline transcription of particular C h genes renders them “accessible” for CSR (Stavnezer-Nordgren & Sirlin, 1986; Yancopoulos et al, 1986).…”